NUNTIUS THERAPEUTICS LIMITED
Company number 13130725 · Monitor this company
Executive summary
Nuntius Therapeutics Limited is an early-stage biotech company exhibiting a solid liquidity position and no compliance issues but operating with consistent losses funded by its US parent. The company’s financial stability is moderately reliant on ongoing capital support, and without revenue generation, risk remains elevated. Further due diligence on the parent company’s backing and the biotech pipeline is critical to form a complete risk assessment.
Shareholders' funds
-£4,145,343
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-01-13
- Employees
- 7 (2025 accounts · was 8 in 2024)
- Registered office
- Unit 23 The Cobalt Building, Lower Pemberton, Ashford, Kent, England, TN25 4BF
- Postcode
- TN25 4BF
- Capital
- 40 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-01-12
- Next due by
- 2027-01-26
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| OPEN CELL 15 PENNARD ROAD, SHEPHERD'S BUSH, LONDON, W12 8DW | 2021-05-25 |
Competitors Ashford
This company ranks 19 among research and experimental development on biotechnology in Ashford.